Westhampton Capital, LLC Biogen Inc. Transaction History

Westhampton Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $392,191 - $590,345	-1,660 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$258.66 - $342.55 $31,039 - $41,106	120 Added 7.79%	1,660 $444,000
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $26,885 - $34,104	-100 Reduced 6.1%	1,540 $487,000
Q3 2019 Oct 16, 2019	BUY	$217.44 - $243.88 $84,801 - $95,113	390 Added 31.2%	1,640 $382,000
Q2 2019 Aug 06, 2019	BUY	$219.29 - $241.72 $274,112 - $302,150	1,250 New	1,250 $292,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Westhampton Capital, LLC with notifications on news.